- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/21 - Retroviridae, e.g. equine infectious anemia virus
Patent holdings for IPC class A61K 39/21
Total number of patents in this class: 1610
10-year publication summary
|
120
|
86
|
103
|
101
|
88
|
88
|
76
|
69
|
75
|
32
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Duke University | 3066 |
84 |
| The Trustees of the University of Pennsylvania | 4323 |
50 |
| The Scripps Research Institute | 1351 |
50 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2853 |
45 |
| International AIDS Vaccine Initiative | 90 |
43 |
| Triad National Security, LLC | 607 |
32 |
| Janssen Vaccines & Prevention B.V. | 295 |
29 |
| The Regents of the University of California | 19929 |
24 |
| Massachusetts Institute of Technology | 10055 |
24 |
| Beth Israel Deaconess Medical Center, Inc. | 858 |
22 |
| Centre National de La Recherche Scientifique | 10432 |
21 |
| American Gene Technologies International Inc. | 93 |
19 |
| Emory University | 1629 |
17 |
| Oregon Health & Science University | 761 |
17 |
| Glaxosmithkline Biologicals S.A. | 1647 |
16 |
| California Institute of Technology | 3972 |
15 |
| Baylor Research Institute | 236 |
15 |
| Inovio Pharmaceuticals, Inc. | 319 |
15 |
| Los Alamos National Security, LLC | 306 |
15 |
| New York University | 1750 |
15 |
| Other owners | 1042 |